Murphy Andrew J reported gift involving 1,054 shares of REGENERON PHARMACEUTICALS, INC. at $0.00 for $0 on Nov 3, 2026

Gift
Form 4 code G. Bona fide gift.
Co-Chief Scientific Officer
Co-Chief Scientific Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
1,054Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
46,779Direct
Trade date
Nov 3, 2026Gift
Filed
Nov 5, 2026, 4:09 PM ET2-day reporting delay
Accession
0001796226-26-000004Code G · Transaction 393431
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

REGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
REGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −19%1w ago −9.6%1d ago +6.5%
Returns since7d +5.3%30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.